Verteporfin protects against Th17 cell‐mediated EAE independently of YAP inhibition

Authors:

Abstract
The known YAP inhibitor verteporfin is capable of repressing IL-17A production in Th17 cells. However, this effect is mediated independently of YAP and can ameliorate Th17-mediated experimental autoimmune encephalomyelitis (EAE) upon in vivo administration. The data suggest verteprofin's mode of action for the design of novel therapeutic autoimmune disease intervention.
Funding Information
  • Deutsche Forschungsgemeinschaft (VI562/7‐1)

This publication has 9 references indexed in Scilit: